Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.44 - $16.72 $2,232 - $5,016
-300 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$15.5 - $21.41 $11,237 - $15,522
-725 Reduced 70.73%
300 $6,000
Q2 2018

Aug 03, 2018

BUY
$17.15 - $17.79 $17,578 - $18,234
1,025 New
1,025 $18,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $449M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.